P
Peter G. Gibson
Researcher at University of Newcastle
Publications - 774
Citations - 53254
Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.
Papers
More filters
Journal ArticleDOI
The role of sensory dysfunction in the development of voice disorders, chronic cough and paradoxical vocal fold movement
TL;DR: The similarity in sensory dysfunction between CC and PVFM provides support for a link between the two conditions and similarities in underlying medical conditions and symptom profiles between CC/PVFM and voice disorders such as muscle tension dysphonia.
Journal ArticleDOI
The effect of maternal asthma on placental and cord blood protein profiles.
Vanessa E. Murphy,Vanessa E. Murphy,Renee F. Johnson,Renee F. Johnson,Yung-Chih Wang,Yung-Chih Wang,Karen O. Akinsanya,Karen O. Akinsanya,Peter G. Gibson,Peter G. Gibson,Roger Smith,Roger Smith,Vicki L. Clifton,Vicki L. Clifton +13 more
TL;DR: A comparative proteomic analysis of placental and umbilical cord blood proteins using surface-enhanced laser desorption ionization-time of flight mass spectrometry to examine the associations among asthma, fetal gender, and protein profiles demonstrates the abilities of the SELDI technique as a tool for protein profiling in tissue or plasma.
Journal ArticleDOI
Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: a clinical audit.
TL;DR: The clinico‐pathological characteristics of community‐acquired MRSA pneumonia are described and it is shown that community‐associated methicillin‐resistant Staphylococcus aureus strains are increasingly causing more invasive infections including severe community-acquired pneumonia.
Journal ArticleDOI
Changes in Expression of Genes Regulating Airway Inflammation Following a High-Fat Mixed Meal in Asthmatics.
TL;DR: Differences in inflammatory gene expression that may contribute to increased airway neutrophilia following a high fat meal in subjects with asthma and may provide useful therapeutic targets for immunomodulation are identified.
Journal ArticleDOI
Efficacy of azithromycin in severe asthma from the AMAZES randomised trial.
Peter G. Gibson,Peter G. Gibson,Ian A. Yang,John W. Upham,John W. Upham,Paul N. Reynolds,Paul N. Reynolds,Sandra Hodge,Sandra Hodge,Alan L. James,Alan L. James,Christine Jenkins,Christine Jenkins,Matthew J. Peters,Guy B. Marks,Guy B. Marks,Melissa Baraket,Heather Powell,Jodie L. Simpson +18 more
TL;DR: Long-term, low-dose AZM reduces asthma exacerbations and improved the quality of life in patients with severe asthma, regardless of how this was defined, and these data support the addition of azithromycin as a treatment option for patients withsevere asthma.